The table below shows Biohaven Ltd.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Operating cash flow
-$149.92M
-$165.12M
-$102.64M
-$77.64M
-$58.84M
Capital expenditure
$0.00
$461.00K
$440.00K
$735.00K
$246.00K
Investing cash flow
$15.21M
$164.88M
$34.03M
-$1.06M
-$246.00K
Dividends paid
-
-
-
-
-
Stock buybacks
-
-
BHVN operating cash flow (10-K history)
Biohaven Ltd. reported operating cash flow of -$609.44M for fiscal year 2025. That is down 4.6% from -$582.45M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$75.96M (FY 2020) to -$609.44M. Figures come from the company's audited annual reports as filed with the SEC.